GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GL Pharm Tech Corp (XKRX:204840) » Definitions » YoY Rev. per Sh. Growth

GL Pharm Tech (XKRX:204840) YoY Rev. per Sh. Growth : 18.75% (As of Mar. 2025)


View and export this data going back to 2014. Start your Free Trial

What is GL Pharm Tech YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. GL Pharm Tech's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2025 was 18.75%.

GL Pharm Tech's Revenue per Share for the three months ended in Mar. 2025 was ₩101.85.

GL Pharm Tech YoY Rev. per Sh. Growth Historical Data

The historical data trend for GL Pharm Tech's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GL Pharm Tech YoY Rev. per Sh. Growth Chart

GL Pharm Tech Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
YoY Rev. per Sh. Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -8.37 -9.15 13.09 51.40 -15.83

GL Pharm Tech Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.47 -1.41 -49.57 -7.58 18.75

GL Pharm Tech YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

GL Pharm Tech's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY Rev. per Sh. Growth (A: Dec. 2024 )
=(Revenue per Share (A: Dec. 2024 )-Revenue per Share (A: Dec. 2023 ))/ | Revenue per Share (A: Dec. 2023 ) |
=(350.734-416.695)/ | 416.695 |
=-15.83 %

GL Pharm Tech's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2025 is calculated as:

YoY Rev. per Sh. Growth (Q: Mar. 2025 )
=(Revenue per Share (Q: Mar. 2025 )-Revenue per Share (Q: Mar. 2024 )) / | Revenue per Share (Q: Mar. 2024 )) |
=(101.854-85.769)/ | 85.769 |
=18.75 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GL Pharm Tech YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of GL Pharm Tech's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

GL Pharm Tech Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GL Pharm Tech Corp (XKRX:204840) » Definitions » YoY Rev. per Sh. Growth
Comparable Companies
XKRX:072020 XKRX:131030 XKRX:004310 XKRX:001540 XKRX:061250 XKRX:002720 XKRX:142280 XKRX:067290 XKRX:002800 XKRX:330350 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA
Traded in Other Exchanges
N/A
Address
137, Sagimakgol-ro, Jungwon-gu, No 714 Jungang Induspia V, Gyeonggi-do, Seongnam, KOR, 462713
Website
http://www.glpt.co.kr
GL Pharm Tech Corp is engaged in developing and marketing pharmaceutical products. It offers products including Incrementally Modified Drugs, Generic Drug and G-SOREN Tab. It also provides generic drugs for cardiovascular, gastric, diabetes, CNS, and respiratory diseases.

GL Pharm Tech Headlines

No Headlines